Jennifer Carver - 17 Aug 2026 Form 4 Insider Report for REVELATION BIOSCIENCES, INC. (REVB)

Reporting relationship: Director
Issuer ticker: REVB
Reported as of: 17 Aug 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 18 Aug 2026, 17:00:04 UTC
Prior SEC filing: 05 Feb 2026
Source filing: View source filing
Reporting owner signature: /s/ J.P. Galda, as attorney-in-fact for Jennifer Carver

Key filing fact

Jennifer Carver filed Form 4 for REVELATION BIOSCIENCES, INC. (REVB) on 18 Aug 2026.

Key facts

This page summarizes Jennifer Carver's Form 4 filing for REVELATION BIOSCIENCES, INC. (REVB).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 18 Aug 2026, 17:00.

Change

Previous filing in this sequence was filed on 05 Feb 2026.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001663163 Primary reporting owner

CARVER JENNIFER

Relationship: Director
Address: C/O REVELATION BIOSCIENCES, INC., 4660 LA JOLLA VILLAGE DR., SUITE 100, SAN DIEGO
Signature: /s/ J.P. Galda, as attorney-in-fact for Jennifer Carver
Signature date: 18 Aug 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

REVB transaction

Common Stock

Award

Transaction value
Shares: +32,011
Change %: +251%
Price: $0.000000^*
Shares after: 44,769
Date: 17 Aug 2026
Ownership: Direct
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

These shares are subject to a restricted stock award granted under the Revelation Biosciences, Inc. 2021 Equity Incentive Plan, with 50% of the shares vesting on the two-year anniversary of the grant date, and the remaining 50% of the shares vesting on the four-year anniversary of the grant date, provided that the Reporting Person remains continuously employed by or provides services to the Company or any subsidiary through the applicable vesting date; and provided, further that such vesting could be accelerated upon the achievement of certain performance milestones.